How to Get Kanuma (Sebelipase Alfa) Covered by Humana in Georgia: Complete Appeals Guide
Quick Answer: Getting Kanuma Covered by Humana in Georgia
Yes, Humana covers Kanuma (sebelipase alfa) for confirmed LAL-D, but requires prior authorization. Your fastest path: Have your prescriber submit a complete PA with enzyme test results showing LAL deficiency, genetic confirmation, and detailed medical necessity letter. If denied, you have 60-65 days for internal appeals, then Georgia external review rights. Start today: Call your prescriber's office and request they begin the Humana PA process immediately while gathering your diagnostic test results.
Table of Contents
- Coverage Basics
- Prior Authorization Process
- Timeline and Urgency
- Medical Necessity Criteria
- Cost and Financial Assistance
- Denials and Appeals Process
- Renewal Requirements
- Specialty Pharmacy Requirements
- Troubleshooting Common Issues
- Frequently Asked Questions
Coverage Basics
Is Kanuma Covered by Humana?
Humana Medicare Advantage plans generally require prior authorization for Kanuma and apply specific coverage criteria for lysosomal acid lipase deficiency (LAL-D). The drug is typically covered as a medical benefit under Medicare Part B since it's an IV infusion given in healthcare facilities.
Which Humana Plans Cover Kanuma?
- Humana Medicare Advantage (MA-PD) plans
- Traditional Humana Medicare with Part D
- Coverage follows Medicare Part B drug rules and Humana's Kanuma medical policy
Note: Kanuma appears on Humana's Medicare Prior Authorization List, confirming PA requirements.
Prior Authorization Process
Step-by-Step: Fastest Path to Approval
- Gather Diagnostic Evidence (Patient/Family)
- LAL enzyme activity test results (dried blood spot preferred)
- LIPA gene sequencing results showing pathogenic variants
- Liver function tests, lipid panel, imaging studies
- Prescriber Submits Complete PA (Clinic)
- Use Humana provider portal or fax
- Include comprehensive medical necessity letter
- Submit within 72 hours for standard decision
- Monitor PA Status (Patient/Clinic)
- Track through Humana member portal
- Follow up if no decision within timeline
- Prepare appeal documents if needed
Required Documentation Checklist
- Confirmed LAL-D diagnosis with enzyme assay results
- Genetic testing showing LIPA gene variants
- Clinical evidence of disease progression
- Specialist prescriber attestation
- Prior treatment history and failures
- Dosing rationale per FDA labeling
Timeline and Urgency
Standard Processing Times
| Process | Timeline | How to Request |
|---|---|---|
| Initial PA | 72 hours | Humana provider portal |
| Expedited PA | 24 hours | Call 1-800-867-6601 |
| Internal Appeal | 7 days | Written redetermination request |
| External Review | 30 business days | Georgia DOI application |
When to Request Expedited Review
Request expedited processing if delay would "seriously jeopardize your life, health, or ability to regain maximum function." For LAL-D, this typically applies to:
- Rapidly progressive disease in infants
- Severe liver dysfunction requiring immediate treatment
- Interruption of ongoing successful therapy
Medical Necessity Criteria
Core Coverage Requirements
Humana's Kanuma policy typically requires:
- Confirmed LAL-D Diagnosis
- LAL enzyme activity < 1.5 nmol/h/mL on validated assay
- Genetic confirmation with pathogenic LIPA variants
- Clinical Evidence
- Progressive liver disease (elevated ALT/AST, hepatomegaly)
- Dyslipidemia with elevated LDL-C and triglycerides
- Growth failure (in pediatric patients)
- Specialist Prescriber
- Metabolic specialist, hepatologist, or geneticist
- Detailed treatment plan and monitoring protocol
- Appropriate Dosing
- Consistent with FDA labeling
- Weight-based dosing every 2 weeks for most patients
Clinician Corner: Your medical necessity letter should explicitly address each Humana criterion, cite relevant clinical guidelines, and explain why Kanuma is the only appropriate treatment option for LAL-D.
Cost and Financial Assistance
Understanding Your Costs
Since Kanuma is typically billed under Medicare Part B:
- Part B deductible applies first
- 20% coinsurance of Medicare-approved amount
- Costs count toward your plan's maximum out-of-pocket limit
Financial Assistance Options
For Commercial Insurance Patients:
- Alexion OneSource CoPay Program - may reduce costs to $0
For Medicare/Humana Patients:
- Medicare patients cannot use manufacturer copay cards
- Alexion OneSource can connect you to third-party foundations
- Patient Advocate Foundation may offer copay relief when funds are available
For All Patients:
- Enroll in Alexion OneSource for insurance navigation support
- Patient Assistance Program for uninsured/underinsured patients
Important: Federal anti-kickback laws prohibit manufacturer copay assistance for Medicare beneficiaries, but third-party foundations may help.
Denials and Appeals Process
Common Denial Reasons and Solutions
| Denial Reason | How to Address |
|---|---|
| Insufficient diagnostic evidence | Submit complete enzyme and genetic testing |
| Not medically necessary | Strengthen medical necessity letter with clinical data |
| Step therapy not met | Document contraindications to alternatives |
| Non-formulary drug | Request formulary exception as only FDA-approved treatment |
Georgia Appeals Process
Level 1: Humana Internal Appeal
- Deadline: 60-65 days from denial notice
- Timeline: 7 days for standard, 72 hours for expedited
- How to file: Humana redetermination form
Level 2: Independent Review Entity (Medicare)
- Deadline: 60 days from Level 1 denial
- Process: Medicare-contracted independent reviewer
Georgia External Review
- Deadline: 60 days from Humana's final denial
- Cost: Free to consumer
- Contact: Georgia DOI Consumer Services at 1-800-656-2298
- Decision: Binding on Humana if approved
When dealing with insurance denials, platforms like Counterforce Health can help turn denials into evidence-backed appeals by analyzing your specific denial reason and drafting targeted rebuttals that align with Humana's own policies.
Renewal Requirements
Re-Authorization Timeline
Humana typically requires re-authorization every 6-12 months for Kanuma. Plan ahead by:
- Scheduling renewal PA submission 30 days before current authorization expires
- Gathering updated lab results (liver enzymes, lipid panel)
- Documenting clinical response and continued medical necessity
- Maintaining regular specialist follow-up appointments
Documentation for Renewals
- Updated enzyme levels and genetic testing (if applicable)
- Evidence of clinical improvement or disease stabilization
- Continued specialist oversight
- Adherence to treatment protocol
Specialty Pharmacy Requirements
Humana's Specialty Pharmacy Network
Humana may require Kanuma be obtained through their contracted specialty pharmacy network for:
- Cold-chain handling and storage
- Prior authorization coordination
- Insurance billing and claims processing
- Patient education and monitoring
What This Means for You
- Your prescription may be transferred to Humana's specialty pharmacy
- Coordinate with your infusion center for drug delivery
- Maintain communication between specialty pharmacy and clinic
Troubleshooting Common Issues
Portal and System Problems
Humana Provider Portal Down:
- Use backup fax submission methods
- Call provider services line on your PA form
- Document submission attempts for appeals
Missing Forms or Documents:
- Contact Humana Member Services
- Request expedited processing if delays affect treatment
- Keep copies of all submissions
Communication Breakdowns
Between Clinic and Specialty Pharmacy:
- Ensure both have current contact information
- Clarify delivery schedules and inventory management
- Establish backup communication methods
Frequently Asked Questions
How long does Humana PA take for Kanuma in Georgia? Standard PA decisions typically take 72 hours for complete submissions. Expedited requests are processed within 24 hours when medical urgency is documented.
What if Kanuma is non-formulary on my Humana plan? Request a formulary exception citing that Kanuma is the only FDA-approved treatment for LAL-D. Include clinical documentation supporting medical necessity.
Can I request an expedited appeal in Georgia? Yes, both Humana internal appeals and Georgia external reviews can be expedited when delays would seriously jeopardize your health.
Does step therapy apply to Kanuma? Step therapy is rarely applied since there are no alternative enzyme replacement therapies for LAL-D. If required, document contraindications to supportive treatments.
What happens if I move from another state to Georgia? Contact Humana to ensure continuity of coverage. Georgia's external review rights may provide additional appeal options not available in your previous state.
How do I find LAL-D specialists in Georgia? Contact Alexion OneSource for referrals to specialists experienced with LAL-D diagnosis and treatment.
Key Takeaways
Getting Kanuma covered by Humana in Georgia requires thorough preparation and understanding of the approval process. Success depends on:
- Complete diagnostic documentation proving LAL-D
- Comprehensive medical necessity letters from specialists
- Timely submission of PA requests and appeals
- Understanding your Georgia appeal rights for additional coverage options
For complex cases or repeated denials, consider working with Counterforce Health, which specializes in turning insurance denials into successful appeals by analyzing payer policies and crafting evidence-based rebuttals tailored to your specific situation.
Sources & Further Reading
- Humana Medical and Pharmacy Coverage Policies
- Humana Medicare Prior Authorization List 2025
- Humana Member Exceptions and Appeals
- Georgia Department of Insurance Consumer Services
- Alexion OneSource Patient Support
- Kanuma Prescribing Information
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and individual circumstances. Always consult with your healthcare provider and insurance plan for specific coverage determinations. For additional consumer assistance in Georgia, contact the Georgia Department of Insurance Consumer Services at 1-800-656-2298.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.